Scarica l'app Stockscreener
0.645
2.71%
-0.018
Dopo l'orario di chiusura:
.63
-0.015
-2.33%
Precedente Chiudi:
$0.663
Aprire:
$0.66
Volume 24 ore:
61,288
Relative Volume:
0.19
Capitalizzazione di mercato:
$2.69M
Reddito:
-
Utile/perdita netta:
$-20.26M
Rapporto P/E:
-0.0755
EPS:
-8.54
Flusso di cassa netto:
$-8.25M
1 W Prestazione:
-0.72%
1M Prestazione:
-24.98%
6M Prestazione:
-44.87%
1 anno Prestazione:
-92.69%
Intervallo 1D:
$0.6111
$0.6682
Intervallo di 1 settimana:
$0.6111
$0.7648
Portata 52W:
$0.6111
$9.60
Oragenics Inc Stock (OGEN) Company Profile
Nome
Oragenics Inc
Settore
Industria
Telefono
813-286-7900
Indirizzo
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
0.645 | 2.76M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Oragenics Inc Borsa (OGEN) Ultime notizie
Oragenics previews targeted milestones for 2026 - Yahoo Finance
Oragenics (OGEN) Progresses ONP-002 for Potential $9 Billion Con - GuruFocus
Oragenics Targets Projected $9 Billion Market by Advancing - GlobeNewswire
Portfolio Shifts: What is the next catalyst for Oragenics IncJuly 2025 Closing Moves & Consistent Return Investment Signals - baoquankhu1.vn
Oragenics partners with Duck Flats Pharma to support FDA IND trial design - Yahoo Finance
Oragenics (OGEN) Partners with Duck Flats Pharma for U.S. IND Re - GuruFocus
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program - Sahm
Oragenics Advances Concussion Treatment Development with SCOPE Summit Participation Ahead of Australian Phase 2a Trial - citybuzz -
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care - GlobeNewswire
Investor Mood: Is Oragenics Inc stock technically oversold2025 Risk Factors & Growth Focused Stock Reports - baoquankhu1.vn
Market Trends: Is now the right time to enter LPLAWeekly Trade Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Rate Hike: What is the next catalyst for Oragenics IncQuarterly Portfolio Summary & Verified Entry Point Detection - baoquankhu1.vn
Oragenics Extends At-the-Market Equity Sales Agreement - The Globe and Mail
Oragenics amends at-the-market sales agreement with Dawson James Securities By Investing.com - Investing.com Australia
Oragenics amends at-the-market sales agreement with Dawson James Securities - Investing.com
Oragenics Signs Amendment to At-the-Market Sales Agreement With Dawson James Securities - TradingView
Telling Fred sells Oragenics (OGEN) shares for $198 By Investing.com - Investing.com Nigeria
Telling Fred sells Oragenics (OGEN) shares for $198 - Investing.com
Sell Signal: What is the target price for Oragenics Inc stockJuly 2025 Short Interest & Fast Moving Trade Plans - baoquankhu1.vn
Aug Chart Watch: What is the next catalyst for Oragenics IncWeekly Earnings Recap & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Oragenics (NYSEAMERICAN:OGEN) Shares Up 1.9% – Should You Buy? - Defense World
Oragenics to Showcase Concussion Treatment Progress at Investor Summit - citybuzz -
Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico - marketscreener.com
OGENOragenics Latest Stock News & Market Updates - Stock Titan
Will Oragenics Inc. stock sustain bullish trend into 2025Portfolio Risk Report & Reliable Intraday Trade Plans - Улправда
Why Oragenics Inc. stock is favored by top institutionsMarket Trend Report & Fast Entry and Exit Trade Plans - Улправда
Can Oragenics Inc. stock deliver surprise earnings beatEarnings Growth Summary & Stepwise Entry and Exit Trade Signals - Улправда
Can Oragenics Inc. stock beat market expectations this quarter2025 Winners & Losers & Community Consensus Trade Alerts - Улправда
Investment Recap: Is Oragenics Inc stock attractive after correctionJuly 2025 News Drivers & Reliable Momentum Entry Alerts - Bộ Nội Vụ
Published on: 2026-01-07 07:41:25 - moha.gov.vn
Why analysts upgrade Oragenics Inc. stock2026 world cup usa national team quarterfinals defensive leaders set piece tactics tactical prediction analysis - Улправда
Is Oragenics Inc. stock vulnerable to rate hikesStock Market Trends & Outstanding Investment Returns - bollywoodhelpline.com
Certain Warrants of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Common Stock of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Convertible Preferred Stock. of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - MarketScreener
Is Oragenics Inc. stock ideal for retirement investorsJuly 2025 Outlook & High Return Stock Watch Alerts - Улправда
Aug Patterns: Why analysts upgrade Oragenics Inc. stockDollar Strength & Weekly Market Pulse Updates - Улправда
Growth Review: Can Oragenics Inc. stock beat market expectations this quarterJuly 2025 Trends & Free Community Consensus Stock Picks - moha.gov.vn
Momentum Shift: Is Oragenics Inc. stock resilient to inflationJuly 2025 Market Mood & Fast Gain Stock Tips - Улправда
Will Oragenics Inc. stock deliver shareholder valueWeekly Profit Report & High Return Trade Opportunity Guides - Улправда
Is Oragenics Inc. stock resilient to inflationJuly 2025 Summary & Verified Short-Term Plans - Улправда
Can Oragenics Inc. stock sustain revenue growthWeekly Market Report & Weekly Chart Analysis and Guides - DonanımHaber
Will Oragenics Inc. stock reach all time highs in 2025Market Growth Summary & Daily Volume Surge Trade Alerts - Улправда
Is Oragenics Inc. stock trading at a premium valuationJuly 2025 Levels & Weekly High Potential Stock Alerts - Улправда
Aug Reactions: Is Oragenics Inc. stock trading at a premium valuationWeekly Trend Summary & Daily Chart Pattern Signal Reports - Улправда
Nasdaq Moves: Is Oragenics Inc. stock ideal for retirement investorsJuly 2025 Volume & Verified Technical Signals - Улправда
Earnings Miss: Will Oragenics Inc. stock reach all time highs in 2025 - Улправда
Oragenics (OGEN) CEO/CFO receives 250,000 stock options at $0.93 - Stock Titan
Oragenics (OGEN) reports immediate-vesting stock option grants to director - Stock Titan
Oragenics Adjusts Executive Compensation Plan - TipRanks
[Form 4] ORAGENICS INC Insider Trading Activity - Stock Titan
Oragenics Inc Azioni (OGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):